A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies
A phase 1/2 trial of IDP-121 in multiple myeloma, diffuse large B-cell lymphoma, non-Hodgkin lymphoma and chronic lymphocytic leukaemia, run by IDP Discovery Pharma S.L., now recruiting.
Overview
A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies is a phase 1/2 interventional study registered as NCT05908409 by IDP Discovery Pharma S.L., with 37 participants planned, started 2023-06-05 and due to reach its primary completion in 2025-12-22. Interventions recorded: IDP-121.
Similar pages
not linked directly; found by shared links- TrialStudy of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
Shares Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma and the tag pipeline.
- TrialSARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
Shares Non-Hodgkin lymphoma (all types), Multiple myeloma and the tag pipeline.
- TrialGene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Shares Non-Hodgkin lymphoma (all types), Chronic lymphocytic leukaemia, Diffuse large B-cell lymphoma and the tag pipeline.
- TrialT-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Shares Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma and the tag pipeline.
- TrialStudy of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
Shares Non-Hodgkin lymphoma (all types), Chronic lymphocytic leukaemia, Diffuse large B-cell lymphoma, Multiple myeloma and the tag pipeline.
- TrialSepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
Shares Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma and the tag pipeline.
- TrialDose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Shares Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma and the tag pipeline.
- TrialStudy of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Shares Non-Hodgkin lymphoma (all types), Chronic lymphocytic leukaemia and the tag pipeline.